Go to Washington Legislature pageGo to House of RepresentativesGo to Senate

State Representative Barbara Bailey - 10th Legislative District

Go to Representative's Home PageBiographyNews and InformationMy BillsDistrict InformationContact Me!Go to Washington House Republicans' Home Page
  Printer-friendly page
 

News from Washington House Republicans.
 

 
FOR IMMEDIATE RELEASE

Feb. 18, 2005

 


More prescription drug bills offer false promises
with risks, says Bailey

The second part of a series of bills that seek to allow Washington to buy prescription drugs from Canada was considered today in the House of Representatives – legislation that Rep. Barbara Bailey says offers only false promises with real risks to the health and safety of our state’s citizens.

House Bill 1316 would have the state seek a waiver from the Food and Drug Administration (FDA) to allow Washington to license Canadian prescription drug wholesalers for importing of their drugs. Bailey, ranking member of the House Health Care Committee, said supporters are seeking the waiver to skirt federal law which prohibits the imports of foreign drugs, including those from Canada.
 
"The FDA has consistently rejected similar waiver requests from other states. And just this week in response to this legislation, the FDA said emphatically said it doesn’t have any waiver authority – that there’s no such provision in federal law," said Bailey, R-Oak Harbor. "Both Canada and the FDA have said they cannot guarantee the safety of Canadian drugs imported into the United States. And the FDA has been very clear that it will not look the other way while we break federal law."

HB 1316 was approved 54-42, with Republicans voting no.

Despite objections, House Bill 1219 also passed along party lines, 55-42. The bill would authorize the state to set up a prescription drug purchasing consortium. Bailey cautioned that this is another step toward putting government in charge of health care by competing with the private sector.  

"For several years, Washington has tried to funnel drug purchases through the government – and where are we now? Where are those savings that were promised? The fact is, those savings never materialized," said Bailey. "This bill would put the government in direct competition with drug wholesalers like Costco or Wal-Mart who buy in bulk and pass the savings onto the consumer. Instead of supporting these businesses, now we want to get into the drug store business and become a Wasco or a Wash-Mart – and compete against them? It’s a very bad idea!"

Bailey said the pharmaceutical companies have begun responding to the needs of citizens by offering free or discounted drugs through pharmacies and websites. She noted since January, one website, Rx Help for Washington.org, has had more than 113,000 inquiries and has identified more than 60,000 low-income patients who qualify for assistance. By comparison, the state has had a discount purchasing program in place since December 2003 and has only assisted about 15,000 Washington residents.

"We all are concerned about the prices of prescription drugs. However, government competing against private businesses is not the answer. Neither are Canadian-imported drugs. Instead, these problems can be solved by fostering a consumer-driven health care system in our state through the private sector by adopting meaningful reforms that will lower costs for all," concluded Bailey.

# # #

For more information, contact: John Handy, Assistant Director: (360) 786-5758
 

 
 

House Republican Communications - (360) 786-7031 * 408 John L. O'Brien Bldg. * Olympia, WA 98504-0600